Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Reissue Patent
2006-03-21
2006-03-21
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
C424S459000, C424S461000, C424S463000, C424S464000, C424S489000
Reissue Patent
active
RE039030
ABSTRACT:
A superior enteric formulation of the antidepressant drug, fluoxetine, is in the form of enteric pellets of which the enteric layer comprises hydroxypropylmethylcellulose acetate succinate.
REFERENCES:
patent: 4017647 (1977-04-01), Ohno et al.
patent: 4018895 (1977-04-01), Molloy et al.
patent: 4194009 (1980-03-01), Molloy et al.
patent: 4314081 (1982-02-01), Molloy et al.
patent: 4444778 (1984-04-01), Coughlin
patent: 4626549 (1986-12-01), Molloy et al.
patent: 4797286 (1989-01-01), Thakkar et al.
patent: 4847092 (1989-07-01), Thakkar et al.
patent: 4853230 (1989-08-01), Lovgren et al.
patent: 4918242 (1990-04-01), Brown
patent: 5104899 (1992-04-01), Young et al.
patent: 5356934 (1994-10-01), Robertson et al.
patent: 5362886 (1994-11-01), Berglund
patent: 5508276 (1996-04-01), Anderson et al.
patent: 687 472 (1995-12-01), None
patent: 0 687 472 (1995-12-01), None
patent: 693 281 (1996-01-01), None
patent: 0 693 281 (1996-01-01), None
patent: 2 057 876 (1981-04-01), None
patent: WO 92/13452 (1992-08-01), None
patent: 92/13452 (1992-08-01), None
patent: 92/19226 (1992-11-01), None
patent: WO 92/19226 (1992-11-01), None
patent: 93/18755 (1993-09-01), None
patent: WO 93/18755 (1993-09-01), None
patent: 93/24154 (1993-12-01), None
patent: WO 93/24154 (1993-12-01), None
patent: WO 95/12385 (1995-05-01), None
patent: 95/12385 (1995-05-01), None
Johnson,World Patents Index, #93-352132, 1993.
Oguiza et al.,World Patents Index, #96-031591, 1996.
Wong et al.,Chemical Abstracts, vol. 124, #156011, 1995.
Montgomery, et al.,Eur. Arch. Psychiatry Clin. Neurosci., 244:211-215 (1994).
Burke, et al.,Psychopharmacol. Bull. 31(3); 524 (1995).
Stafford, et al.,Drug Development and Industrial Pharmacy, 8(4):513-530 (1982).
Osterwald, Hermann P.,Pharmaceutical Research, 2:14-18 (1985).
Davis, et al.,Drug Development and Industrial Pharmacy, 12(10):1419-1448 (1986).
Bloor, et al.,Drug Development and Industrial Pharmacy, 15(15-16):2227-2243.
Nagai, et al.,Aqueous Polymeric Coating for Pharmaceutical Dosage Forms, Marcel Dekker, N.W. and Basel, 81-152 (1989).
Chang, Rong-Kuo,Pharmaceutical Technology, 14(10):2-70 (1990).
Fujii, et al., Recent Advances On Aqueous Polymeric Coating System and Related Techniques, Proceedings of Pre-World Congress Particle Technology in Gifu, Sep. 17-18, 1990, Gifu, Japan, 80-85 (1990).
Delattre, et al.,Proceed. Intern. Symp. Control Rel. Bioact. Mater., 19:267-268 (1992).
Schmidt, et al.,Drug Development and Industrial Pharmacy, 18(18):1969-1979 (1992).
Wyatt, “Enhanced Stability of Aqueous Cellulose Acetate Phthalate (CAP) Enteric Films.” Presented AASP Annual Meeting, San Antonio, TX, Nov. 15-19, 1992.
Takahata, et al.,Chemical and Pharmaceutical Bulletin, 41(6):1137-1143 (1993).
Obara, et al.,Pharmaceutical Research, 11(11):1562-1567 (1994).
Shin-Etsu Chemical Co., Ltd., “An Improved Aqueous Coating Using Shin-Etsu AQOAT”, AQOAT Technical Information Bulletin, 1994.
Japan Pharmaceutical Excipients Council, “Hydroxypropylmethylcellulose Acetate Succinate”, Japanese Pharmaceutical Excipients 1993 (JPE 1993), 183-187, Yakuji Nippo, Ltd., Tokyo, Japan, 1994.
Shin-Etsu Chemical Co., Ltd. “Dry Coating”, AQOAT Technical Inormation No. A-3, Sep., 1996.
Obara, et al., Poster PT6115, Dry Coating′—A Novel.
Montgomery et al.,Lack of Efficacy of Fluoxetine in Recurrent Brief Depression and Suicidal Attempts, Eur. Arch. Psychiatry Clin. Neurosci. (1994), 244:211-215.
Burke et al.,Weekly Fluoxetine Controls Symptoms of Depression, Psychopharmacology Bulletin (1995), 31(3):524.
Stafford et al.,Enteric Film Coating Using Completely Aqueous Dissolved Hydroxypropyl Methyl Cellulose Phthalate Spray Solutions, Drug Dev. And Industrial Pharmacy (1982), 8(4):513-530.
Osterwald, H.P.,Properties of Film-Formers and Their Use in Aqueous Systems, Pharmaceutical Research (1985), 2(1):14-18.
Davis et al.,Preparation and Stability of Aqueous-Based Enteric Polymer Dispersions, Drug. Dev. And Industrial Pharmacy (1986), 12(10):1419-1448.
Bloor et al.,The InVitro and InVivo Performance of Aqueous Based Enteric Coats of Neutralised Hydroxypropyl Methyl Cellulose Phthalate, Drug Dev. And Industrial Pharmacy (1989), 15(14-16):2227-2243.
Nagai et al.,Ch. 3—Applications of HPMC and HPMCAS Aqueous Film Coating of Pharmaceutical Dosage Forms, Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms (1989), pp 81-152.
Chang, R.,A Comparison of Rheological and Enteric Properties Among Organic Solutions, Ammonium Salt Aqueous Solutions, and Latex Systems of Some Enteric Polymers, Pharm. Tech. (Oct. 1990), 14(10):2-70.
Fujii et al.,Coating Technique of Granules with Hydroxypropylmethylcellulose Acetate Succinate, Recent Advances on Aqueous Polymeric Coating System and Related Techniques (Sep. 1990) pp 80-85.
DeLattre et al.,Enteric Film Coating With Aqueous Solutions of Hydroxypropylmethylcellulose Acetate Succinate, Proceed. Intern. Symp. Control. Rel. Bioact.Matter (1992) 19:267-268.
Schmidt et al.,The MiniWiD-Coater: II. Comparison of Acid Resistance of Enteric-Coated Bisacodyl Pellets Coated with Different Polymers, Drug Dev. And Industrial Pharmacy (1992), 18(18):1969-1979.
Wyatt, D.M.,Enhanced Stability of Aqueous Cellulose Acetate Phthalate(C-A-P)Enteric Films, 7thAnnual AAPS Conf. (1992) pp 1-5.
Takahata et al.,Microencapsulation of Benzoic Acid Derivatives Using an Enteric Polymer by Surface Neutralization Method and Derivation of an Empirical Equation for Predicting Film Formation, Chem. Pharm. Bull. (1993), 41(6):1137-1143.
Obara et al.,Properties of Free Films Prepared from Aqueous Polymers by a Spraying Technique, Pharm. Res. (1994), 11(11):1562-1567.
Shin-Etsu Chemical Co., Ltd.,An Improved Aqueous Coating Using Shin-Etsu AQOAT, Shin-Etsu Tech. Information Bull. (Feb. 1994) pp 1-14.
Yakuji Nippo, Ltd.,Hydroxypropylmethylcellulose Acetate Succinate, Japanese Pharmaceutical Excipients (1993) pp 182-187.
Shin-Etsu Chemical Co., Ltd., “Dry Coating”, An Innovative Enteric Coating Using Shin-Etsu AQOAT®, Shin-Etsu Tech. Information No. A3. (Sep. 1996) pp 1-7.
Obara et al., “Dry Coating”, A Novel Enteric Coating Method Using a Cellulose Derivative, Pharm. Res. (Sep. 1996)—PT6115, 13(9):S-185.
Corey et al.,Enantioselective and Practical Syntheses of R- and S-Fluoxetines, Tetrahedron Letters (1989), 30(39):5207-5210.
Johnson, K.H.,World Patents Index, #93-352132 (1993).
Oguiza, et al.,World Patents Index, #96-031591 (1996).
Wong et al.,World Patents Index, vol. 124, #156011 (1995).
Benfield et al.,Fluoxetine, A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in Repressive Illness, Drugs (1986), vol. 32, pp 481-508.
Wirth et al.,Maillard Reaction of Lactose and Fluoxetine Hydrochloride, a Secondary Amine, Journal of Pharmaceutical Sciences (Jan. 1998), 87(1):31-39.
Anderson Neil Robert
Harrison Roger Garrick
Lynch Daniel Frederick
Oren Peter Lloyd
Eli Lilly and Company
Joynes Robert M.
Page Thurman K.
Titus Robert D.
LandOfFree
Fluoxetine enteric pellets and methods for their preparation... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluoxetine enteric pellets and methods for their preparation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluoxetine enteric pellets and methods for their preparation... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3574057